2011
Evaluation of ER/PR and HER2 status by RNA sequencing in tissue core biopsies from preoperative clinical trial specimens.
Kamalakaran S, Lezon-Geyda K, Varadan V, Banerjee N, Lannin D, Rizack T, Sikov W, Abu-Khalaf M, Janevski A, Harris L. Evaluation of ER/PR and HER2 status by RNA sequencing in tissue core biopsies from preoperative clinical trial specimens. Journal Of Clinical Oncology 2011, 29: 46-46. DOI: 10.1200/jco.2011.29.27_suppl.46.Peer-Reviewed Original ResearchER/PRVe tumoursCore biopsyHER2 statusER-ve tumoursPreoperative clinical trialHER2 IHC 2Breast core biopsyTissue core biopsyFresh frozen biopsiesPAM50 analysisNab-paclitaxelER statusClinical statusIHC 2Clinical trialsMolecular subtypesPatient tumorsBreast cancer transcriptomeClinical utilityTherapy trialsTumorsMolecular subtypingBiopsyPAM50 classification
1989
Fine‐needle aspiration cytology of breast masses in pregnant and lactating women
Finley J, Silverman J, Lannin D. Fine‐needle aspiration cytology of breast masses in pregnant and lactating women. Diagnostic Cytopathology 1989, 5: 255-259. PMID: 2791833, DOI: 10.1002/dc.2840050305.Peer-Reviewed Original ResearchConceptsFine-needle aspiration biopsyBreast massesAspiration biopsyFine needle aspiration cytologyAbundant vacuolated cytoplasmFalse-positive diagnosesInflammatory backgroundLobular hyperplasiaPregnant womenCytologic examinationPostpartum periodMicrotissue fragmentsAspiration cytologyClinical utilityEpithelial groupsNuclear pleomorphismVacuolated cytoplasmCellular smearsIrregular nucleoliMorphologic featuresProteinaceous debrisEpithelial cellsWomenBiopsySecretory type